R&D

Siva Therapeutics is expanding its R&D pipeline.  Initially we are targeting skin cancer and bladder cancer - two diseases that affect millions of people worldwide with often tragic consequences.  Future areas of growth are new cancer targets, new diagnostic devices, and new R&D projects that represent improved ways to detect and treat cancer using the rapidly developing field of nanotechnology.

---